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ABSTRACT: Arsenic is a widespread environmental
contaminant. However, the exact molecular mechanisms
underlying the carcinogenic effects of arsenic remain
incompletely understood. Core histones can be ubiquiti-
nated by RING finger E3 ubiquitin ligases, among which
the RNF20-RNF40 heterodimer catalyzes the ubiquitina-
tion of histone H2B at lysine 120. This ubiquitination
event is important for the formation of open and
biochemically accessible chromatin fiber that is conducive
for DNA repair. Herein, we found that arsenite could bind
directly to the RING finger domains of RNF20 and
RNF40 in vitro and in cells, and treatment with arsenite
resulted in substantially impaired H2B ubiquitination in
multiple cell lines. Exposure to arsenite also diminished the
recruitment of BRCA1 and RAD51 to laser-induced DNA
double-strand break (DSB) sites, compromised DNA DSB
repair in human cells, and rendered cells sensitive toward a
radiomimetic agent, neocarzinostatin. Together, the results
from the present study revealed, for the first time, that
arsenite may exert its carcinogenic effect by targeting
cysteine residues in the RING finger domains of histone
E3 ubiquitin ligase, thereby altering histone epigenetic
mark and compromising DNA DSB repair. Our results
also suggest arsenite as a general inhibitor for RING finger
E3 ubiquitin ligases.
Owing to its natural abundance and industrial use, arsenic’senvironmental impact is felt by nearly 150 million people
in more than 70 countries.1 Epidemiological studies revealed that
human exposure to arsenic in drinking water is significantly
associated with the prevalence of skin, lung, and bladder
cancers.2−4 Inhibition of DNA repair has been suggested as a
major mechanism in arsenic genotoxicity.5 In this respect,
humans exposed to arsenite in drinking water were found to have
increased frequencies of chromosome aberrations in peripheral
lymphocytes and elevated frequencies of micronuclei in
exfoliated cells.5 The inhibition of DNA repair might be
attributable to the formation of three-coordinate trigonal-
pyramidal complexes with cellular cysteine-containing proteins,6
where arsenite was previously found to displace Zn2+ in the zinc
finger motifs of some DNA repair proteins including poly(ADP-
ribose) polymerase 1 (PARP1) and XPA.7−11
Aside from the carcinogenic effect of arsenic species, trivalent
arsenic, in the form of arsenic trioxide, has demonstrated
remarkable success in the clinical treatment of acute
promyelocytic leukemia.12 In this regard, As(III) was found to
bind to the RING finger domain of PML in the oncogenic PML-
RARα fusion protein, and this binding ultimately results in the
proteasomal degradation of the fusion protein.13 RING finger, a
protein structural domain of the zinc-finger type containing a
Cys3HisCys4 amino acid motif, is also present in the majority of
E3 ubiquitin ligases.14 Among them, the RNF20-RNF40
heterodimer targets histone H2B lysine 120 (K120) for
monoubiquitination, and this ubiquitination event is important
for decompacting the 30 nm chromatin fiber15 and facilitating
DNA double-strand break (DSB) repair.16,17 We reasoned that
arsenite may also bind to the RING finger motifs of RNF20 and
RNF40, thereby perturbing H2B ubiquitination and suppressing
DNA DSB repair.
To investigate whether NaAsO2 can bind directly to the RING
finger domain of RNF20 and RNF40, we performed in vitro
binding assays using synthetic RING finger peptides of the two
proteins. MALDI-TOF MS results revealed mass increases of 72
and 144Da upon incubation of the peptides with arsenite (Figure
1a). The +72 Da mass shift reflects the binding of As(III) to the
RING finger peptides with the release of three protons,
suggesting the coordination of As(III) with three cysteines.10
The MS data, therefore, suggest that each molecule of the RING
finger peptides can bind up to two As(III).
Thiol coordination to As(III) gives rise to new charge-transfer
electronic transitions in the near UV range (250−320 nm) that
can be monitored by UV absorbance.18 We found, from optical
absorption experiments, that the two RING finger peptides
displayed increased absorbance in this wavelength range upon
addition with increasing amounts of NaAsO2 (Figure 1b).
18
Together, these assays demonstrated that NaAsO2 can bind to
sulfhydryl group of cysteine residues in the RING finger domains
of RNF20 and RNF40 in vitro.
We next investigated the binding of arsenite with the RING
domains of RNF20 and RNF40 in cells. To this end, we
synthesized a biotin-As probe by conjugating p-aminopheny-
larsine oxide (PAPAO) with biotin19,20 and assessed arsenite
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binding by streptavidin agarose affinity assay. Our results showed
that the treatment of cells with biotin-As facilitated the pull-down
of ectopically expressed RNF20 and RNF40, suggesting that
RNF20 and RNF40 can bind to the biotin-As probe in cells
(Figures 2a and S1a). Moreover, we failed to pull down the two
proteins when the cells were pretreated with NaAsO2 or PAPAO,
though pretreatment with Zn2+ still led to the successful pull-
down of the two proteins, demonstrating that the interactions
between biotin-As and RNF20 or RNF40 are specific (Figures 2a
and S1). To determine if the cysteine residues in the RING finger
domains are required for such interactions, we mutated the two
cysteine residues in each of the two Zn2+-binding sites of the
RING finger motifs of RNF20 and RNF40 to alanines (i.e., the
C922,924A and C957,960A mutants for RNF20 and the
C948,950A and C983,986A mutants for RNF40) and conducted
the same pull-down assays. Our results showed that the
mutations abolished the pull-down of the two proteins (Figure
2a), indicating that an intact RING finger is indispensable for the
interaction between biotin-As and RNF20 or RNF40. Along this
line, Western analysis revealed that the mutations did not lead to
decreased expression of the two proteins (Figure S1).
We further examined arsenite binding by performing
fluorescence microscopy experiments with the use of ReAsH,
which displays no red fluorescence until its arsenic moieties bind
to nearby cysteine sulfhydryl groups in proteins.21 We found that
the GFP-conjugated RNF20 or RNF40 can bind to As(III) in
ReAsH as manifested by the emission of red fluorescence from
the dye in ReAsH-treated cells (Figures 2b and S2).
Furthermore, ReAsH colocalized to nuclear foci with GFP-
fused RNF20 and RNF40 in HEK293T cells. Such colocalization
was abolished when the cells were pretreated with NaAsO2 or
PAPAO (but not with Zn2+) or when two of the RING finger
cysteine residues were mutated to alanines (Figure 2b,c). These
results demonstrate that As(III) interacts directly with RNF20
and RNF40 in human cells and such interactions necessitate the
intact RING finger motif. In this respect, the background red
signal observed for cells pretreated with PAPAO or NaAsO2 or
cells transfected with mutant RNF20/RNF40 might be
attributed to the interactions between As(III) and other cellular
proteins.
The RNF20-RNF40 heterodimer induces the ubiquitination
of histone H2B at K120, which is important in transcription
elongation.22,23 Recently this ubiquitination was also found to be
required for decompacting the 30 nm chromatin fiber15 and play
a crucial role in DNA DSB repair via the homologous
recombination (HR) and nonhomologous end-joining (NHEJ)
pathways.16,17 In this context, cells lacking RNF20 exhibit
reduced recruitment of HR and NHEJ factors to DSB sites and
display markedly enhanced sensitivity to ionizing radiation and
neocarzinostatin (NCS), a radiomimetic drug.16,17 We reasoned
that the binding of arsenite to the RING finger motifs of RNF20
and RNF40 might diminish the heterodimer’s capability in
inducing ubiquitination of histone H2B at K120 thereby
suppressing DNA DSB repair. To test this hypothesis, we
extracted core histones from the control and arsenite-treated
cells and monitored the levels of H2B K120 ubiquitination by
Figure 1. In vitro binding between NaAsO2 and RING finger peptides of
RNF20 and RNF40. (a) MALDI-TOF mass spectrometry for
monitoring the interaction between arsenite and the RING finger
peptides of RNF20 and RNF40. The molar ratios between the RING
finger peptides and arsenite were 1:2. (b) UV absorption spectra of the
RING finger peptides titrated with increasing amounts of NaAsO2.
Figure 2. Binding between NaAsO2 and the RING finger domains of
RNF20 and RNF40 in cells. (a) Streptavidin agarose affinity pull-down
assay using biotin-As as a probe revealed the binding of As(III) with
RNF20 or RNF40 in cells. Pretreatment of cells with 10 μMNaAsO2 or
PAPAO for 1 h attenuated the binding, and mutations of RING finger
cysteines to alanines abrogated the pull-down of RNF20 and RNF40
with the biotin-As probe. (b) Colocalization of As(III)-bearing ReAsH
with GFP-RNF20 and GFP-RNF40 in HEK293T cells, and such
colocalization is lost in cells pretreated with 10 μMNaAsO2 or PAPAO,
but not Zn2+. (c) Mutations of RING finger cysteines to alanines
abolished the colocalization of RNF20 or RNF40 with ReAsH.
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using LC-MS/MS (Figures 3a and S3).24 It turned out that a 24 h
treatment with 5 μM NaAsO2 led to a significant diminution in
the levels of H2B K120 ubiquitination in multiple cell lines
(Figure 3b). The decreased ubiquitination could be attributed to
the aggregation of the RING finger proteins stimulated by
As(III) binding. In this vein, our refolding experiment revealed
that As(III), but not Zn2+, could promote the aggregation of the
RING finger motif of RNF20 in vitro (Figure S4).
We next investigated whether arsenite-induced perturbation in
H2B K120 ubiquitination confers diminished recruitment of
DNA repair proteins to DNA DSB sites. To this end, we
employed immunofluorescence microscopy to follow the
recruitment of BRCA1 and RAD51 to laser-induced DNA
DSB sites. Our results revealed that treatment with arsenite led to
marked decreases in the recruitment of these two proteins to
laser-induced DNA DSB sites (Figure 4). Additionally, the
diminished recruitment of these two proteins is not due to their
decreased expression, as real-time PCR results showed that
arsenite treatment did not lead to decreased expression of
BRCA1, RAD51, or several other genes important in DNA DSB
repair (i.e., XRCC1, Ku70, and Ku80; Figure S5).
Diminished histone H2B ubiquitination and the ensuing
compromised recruitment of DNA repair factors to DNA DSB
sites may perturb DSB repair. To test this, we utilized U2OS cells
with a chromosomally integrated copy of DR-GFP and EJ5-GFP
reporters to examine whether arsenite treatment leads to
compromised DNA DSB repair via the HR and NHEJ
pathways.25 DR-GFP contains the SceGFP cassette, where the
GFP coding sequence is interrupted by a single recognition site
of the rare-cutting I-SceI nuclease and a 5′ and 3′ truncated
fragment of GFP (iGFP).25 HR-directed repair of the I-SceI-
induced DSB leads to the restoration of a functional GFP gene.25
EJ5-GFP carries the pCAGGS promoter separated from the rest
of aGFP expression cassette flanked by two I-SceI sites; NHEJ of
I-SceI-produced distal DSB ends results in the restoration of the
GFP cassette.25 Flow cytometry-based measurement of GFP-
positive U2OS cells after I-SceI transfection facilitated us to
quantify the levels of HR and NHEJ in control and arsenite-
treated cells. Our results revealed that arsenite exposure led to
significantly diminished repair of DSBs via the HR and NHEJ
pathways (Figures S6 and S7a). It is of note that treatment with
NaAsO2 did not alter the transfection efficiency (Figure S7b) or
interfere with the GFP-based reporter assays for monitoring HR
and NHEJ activities. In the latter respect, our control
experiments showed that, without I-SceI transfection, the
percentages of GFP-positive U2OS cells are similar in the
presence or absence of NaAsO2 treatment (Figure S7a).
Moreover, consistent with the diminished DNA DSB repair,
we found, from clonogenic survival assay, that treatment with
arsenite renders HEK293T cells more sensitive toward treatment
with NCS, a radiomimetic drug (Figure S8).
Trivalent arsenic is a known human carcinogen. Although
arsenite has been shown to bind and inhibit the activity of zinc
finger-harboring DNA repair proteins (i.e., XPA and
PARP1),7−10 this is the first report to demonstrate that arsenite
can bind to the RING finger domains of a histone E3 ubiquitin
ligase, which perturbs histone epigenetic mark and compromises
DNA DSB repair. In this vein, DNA DSBs can emanate from
collapse of replication fork, processing of DNA interstrand cross-
links, or following exposure to ionizing radiation.26,27 DNADSBs
are among the most deleterious types of DNA lesions; failure to
repair DSBs can lead to cell death or promote chromosomal
rearrangements, which in turn can stimulate malignant trans-
Figure 3.NaAsO2 inhibits histone H2B K120 ubiquitination in cells. (a)
The product-ion spectrum (MS/MS) of the [M + 2H]2+ ion of the
tryptic peptide AVTKGGVTSSK from histone H2B, where K120 is
modified with a diglycine remnant. An asterisk (*) indicates those ions
bearing a diglycine moiety. (b) Relative levels of H2B ubiquitination in
GM00637, IMR90, andHEK293T cells without or with a 24 h treatment
of 5 μM NaAsO2.
Figure 4.NaAsO2 suppresses the recruitment of BRCA1 and RAD51 to
DSB sites. (a) Immunofluorescence displaying that the treatment of
HeLa cells with NaAsO2 compromises the recruitment of BRCA1 and
RAD51 to laser-induced DNA DSB sites. (b) Quantified percentages of
cells recruiting BRCA1 and RAD51 to DSB sites upon treatment with 0,
5, and 20 μMofNaAsO2. The p values were calculated by using unpaired
two-tailed t-test.
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formation.28 Thus, arsenite may exert its carcinogenic effect
partly through inhibiting DNA DSB repair. In keeping with its
inhibitory effect on DNA repair, we also found that arsenite
sensitizes cells toward a radiomimetic drug. Considering that
ionizing radiation is widely used in cancer treatment, our results
suggest the potential application of arsenite as a sensitizing agent
for cancer radiation therapy.
Maintaining an open and biochemically active chromatin
conformation is also important for proteins involved in other
DNA repair pathways to access damage sites in chromatin. Thus,
compromised H2B K120 ubiquitination arising from arsenite
exposure may also account for the diminished repair of other
types of DNA lesions.
Our findings that arsenite may promote cancer development
through binding to the RING finger domains of a histone E3
ubiquitin ligase is reminiscent of the mechanism underlying
arsenite’s role as a chemotherapeutic agent for the treatment of
acute promyelocytic leukemia. In the latter case, arsenite binds
directly to the RING finger motif of the PML-RARα fusion
protein, which triggers eventually the proteasomal degradation of
the oncoprotein.13 Viewing the crucial roles of the ubiquitin-
proteasome system in physiology and pathophysiology and the
fact that the majority of the E3 ubiquitin-protein ligases harbor
RING finger or RING finger-related motifs,14 our study suggests
that arsenite may also perturb ubiquitination events mediated by
other RING finger E3 ubiquitin ligases. In this context, the
reduced efficiency in HR and NHEJ repair may also arise, in part,
from the interaction between arsenite and other RING finger E3
ubiquitin ligases that are important in DNA damage response
and repair. Along this line, we observed that As(III) can also bind
to the RNF8 and RNF168 histone E3 ubiquitin ligases (Figures
S9−S11). Thus, arsenite may be considered as a general inhibitor
for RING finger E3 ubiquitin ligases. Together, our results
support the notion that As(III) may induce the remission of
acute promyelocytic leukemia and cancer development on the
basis of the same chemical rationale (i.e., through binding to
RING finger proteins), albeit on different molecular targets (i.e.,
PML-RARα oncoprotein in one case, and RING finger histone
E3 ubiquitin ligases in the other).
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